(217) found that the iron chelator deferoxamine can inhibit pathways such as TGF-β1/Smad3, inflammatory response, and oxidative stress, thereby alleviating renal fibrosis in CKD rats. This evidence concerns the gene TGFB1 and renal fibrosis.